Overview

A Study to Evaluate Treatment Adherence in Schizophrenia With Long Acting Risperidone Microspheres (e-STAR)

Status:
Completed
Trial end date:
2009-06-01
Target enrollment:
Participant gender:
Summary
This study is a non-interventional web based registry designed to assess demographic, treatment and outcomes data in patients receiving treatment with long-acting injectable risperidone. One year retrospective data and 2 year prospective data will be collected.
Details
Lead Sponsor:
Janssen Korea, Ltd., Korea
Treatments:
Risperidone